Additionally, high serum exosomal MIAT predicted shorter overall (p = 0.022) and recurrence‐free survival (p = 0.002), and served as an independent prognostic factor for GC (HR = 3.46; p = 0.007).[26] In contrast, lnc‐GNAQ‐6:1 was significantly under‐expressed in GC patients (p = 0.0010). The gene discussed is GNAQ; the disease is gastric cancer.